All News

Researchers and senior physicians support a French official’s warning that individuals showing symptoms of the novel coronavirus should use paracetamol rather than ibuprofen.

Some pharmacists and technicians are reporting that they don’t have enough personal protective equipment behind the counter.

Recently, many providers have become worried about the potential of certain medications to worsen transmission and outcomes in the setting of the global COVID-19 pandemic.

Patients who received an opioid after tooth extraction reported higher levels of pain than patients who received a non-opioid.

Conferences such as the American Pharmacists Association (APhA) 2020 Annual Meeting and Expo are now implementing virtual versions of their programs.

A new study shows that the advantages of digital breast tomosynthesis are maintained over multiple years and rounds of screening compared with digital mammography.

Although vaccine development is underway, the process can take at least a year before reaching in the mass-production stage.

West Virginia legislature passes a bill that will affect reimbursement for services that fall within a pharmacist’s purview and are ordinarily provided by other health care providers.

More than 10% of COVID-19 patients were infected by an asymptomatic person, according to new research.

Top news from across the health care landscape.

The goals of the expansion are to maintain social distancing and to avoid overburdening hospitals with patients.

A 72-week interim analysis of observational data from the ongoing SEARCH study was used to examine optimal strategies for PrEP engagement and uptake after population-level HIV testing and universal PrEP access.

Several pharmaceutical companies are racing to develop an effective treatment for the virus that is now a global pandemic.

A clinical program evaluating sarilumab (Kevzara, Sanofi and Regeneron) has started in patients hospitalized with a severe form of the novel coronavirus (COVID-19), according to the company.

The authorizations have been given to Hologic for its Panther Fusion SARS-CoV-2 Assay and to Laboratory Corporation of America for its COVID-19 reverse transcription polymerase chain reaction test.

Aimmune’s peanut allergen power was approved by the FDA as an oral immunotherapy indicated for the mitigation of allergic reactions, including anaphylaxis, that may occur with accidental exposure to peanut.

A new executive order from Kentucky Gov. Andy Beshear has expanded prescribing rights to pharmacists in light of the novel coronavirus.

The spray is the first nasal spray treatment for seizure cluster rescue.

In an appeal to all Americans, Deborah Birx, MD, said everyone has a role in stopping COVID-19 from spreading.

The first clinical trial evaluating an investigational vaccine designed to protect against the novel coronavirus (COVID-19) has begun.

Protecting pharmacy staff is vital to ensuring continued care during the COVID-19 outbreak.

French health officials have warned that widely used OTC anti-inflammatory drugs may worsen the novel coronavirus known as COVID-19, whereas others say more evidence is needed.

How can this patient better tolerate polyethylene glycol (PEG)-electrolyte lavage solution?

In response to growing concern surrounding the novel coronavirus, Cedarville University School of Pharmacy and Cedar Care Village Pharmacy presented an online town hall meeting with an infectious disease expert.

As one of the most visible members of the health care team, pharmacists are uniquely positioned to assist and support patients in tobacco cessation.

Pharmacies across the country also taking necessary steps to help facilitate COVID-19 testing and to keep patients safe.

A growth hormone known as insulin-like growth factor-1 has been found to play a role in the development of breast cancer.

Top news from across the health care landscape.

Providing specialty pharmacy services to patients who need those medications allows health care organizations to benefit from additional revenues generated from specialty drugs and improved care for patients requiring them.

The new guidance for industry (GFI) document, “Policy for Temporary Compounding of Certain Alcohol-Based Hand Sanitizer Products,” was released Saturday.